Transcription Initiation factor TFIIF is a tetramer consisting of two large subunits (TFllFa or RAP74) and two small subunits (TFIIFp or RAP30). We report here the molecular cloning of a Drosophila cDNA encoding TFIIFp. The cDNA clone contains an open-reading frame encoding a 277 amlno acid polypeptlde having a calculated molecular mass of 32107 Da. Comparison of the deduced amino acid sequence with the corresponding sequences from vertebrates showed only 50% identity, with four insertion/deletion points. For transcription activity in a TFIIF-depleted Drosophila nuclear extract, both TFllFa and TFIIFP are essential. Moreover, Drosophila TFIIFp interacts with both Drosophila and human TFllFa In vitro. Thus we conclude that Isolated cDNA encodes bona fide TFIIFp. The structural domains of TFIIFp and its sequence similarity to bacterial a factors are discussed.
INTRODUCTION
In addition to RNA polymerase II, accurate transcription initiation in vitro requires at least six general transcription initiation factors: TFIIA, TFIIB, TFIID, TFUE, TFIIF and TFIIH (see 1,2 for reviews). The first step in preinitiation complex formation involves TFTID binding to the TATA box in the promoter region, an interaction which may be facilitated by TFHA. Next, TFIIB binds to the TFTID-promoter complex and recruits the preformed RNA polymerase II-TFUF complex to the promoter. The subsequent binding of other factors completes formation of the functional complex which is able to initiate transcription. Recently, we and others have cloned various subunits of Drosophila TFIID, consisting of TATA-box binding polypeptide (TBP) and TBP associated factors (TAFs) (see 3,4 for reviews). TFIID subunits are potential targets for activators and play a central role in transducing signals from sequencespecific activators into increased performance of the RNA polymerase II transcription machinery (1, 2) . A recent report (5) suggests that TFIIF is a candidate for mediator between TFIID and RNA polymerase II in the activation pathway. Thus, the cloning of Drosophila TFHF is quite important for understanding the activation pathway, especially for determining the functional interactions among the recently isolated TFIID components.
TFIIF is composed of two large subunits (TFIIFa or RAP74) and two small subunits (TFIIFP or RAP30). Although both have been cloned from vertebrates (6) (7) (8) (9) (10) (11) (12) (13) , only TFIIFa has been cloned from Drosophila (14, 15) . Here we report the cloning of the Drosophila TFUFP and demonstrate the functional properties of these polypeptides.
MATERIALS AND METHODS

Isolation of the cDNA and genomic clone encoding Drosophila TFIIFP
A Drosophila embryo cDNA library (16) , was screened with a random-primed probe containing the entire coding sequence of human TFIIFp. Filters were hybridized with probe (1 x 10 6 c.p.mJml) in 5 x SSPE/0.1% SDS at 50°C overnight and washed with 2 x SSPE/0.1% SDS at 45°C for 2 h. A cDNA clone with the longest insert DNA was subcloned into plasmid Bluescript KS + (Stratagene) and sequenced by the dideoxynucleotide chain terminating method (US Biochemicals). A genomic clone was obtained by screening of a Drosophila genomic library EMBL-3 (Stratagene) with a random-primed Drosophila TFIIFP cDNA and used for chromosomal in situ hybridization.
Chromosomal in situ hybridization
Salivary glands were dissected from wandering third instar larvae in a mixture of acetic acid:water:lactic acid (3:2:1), flattened between a microscope slide and siliconized cover slip and left at 4°C overnight Slides were then frozen in liquid nitrogen, coverslips were removed and the chromosomes dehydrated in ethanol. Prior to hybridization, slides were heated to 70°C for 30 min in 2 x SSCP and then dehydrated in ethanol. They were then denatured in 70 mM NaOH for 2.5 min and dehydrated again. Biotinylated probes were prepared by random priming (BioPrime * To whom correspondence should be addressed DNA Labelling System, Gibco-BRL) of the Drosophila TFIIFP genomic clone. Biotinated probe (10 ng per slide) was hybridized overnight in 10 (J.1 hybridization buffer (50% formamide, 4 x SSCP, 1 x Denhardht's solution, 10% dextran sulfate, 4 mg/ml sheared denatured DNA) overnight at 37°C. Slides were then washed three times at 65°C in 2 x SSCP for 30 min. Signal was detected using a streptavidin-alkaline phosphatase conjugate and examined on a Zeiss Axiophot.
Expression and purification of recombinant TTIIF
For expression and purification of Drosophila TFUFa (14), a baculovirus system was used A histidine tag was introduced at the N-terminal end of TFIIFa by in vitro mutagenesis with the oligodeoxynucleotide 5'-GACTTTGACGCGCTCGAATGATGATGATGATGATGTCCCATGGCrTAATGTTTGC-3'. The resulting fragment was subcloned into the baculovirus expression vector pVL1393 (Pharmingen). The recombinant virus was obtained using a BaculoGold system according to the instruction from the manufacturer (Pharmigen). Recombinant polypeptide was purified from infected Sf9 cells as described previously (17) . Briefly, cell suspension was disrupted with brief sonication in Buffer B [40 mM Tns-HCl (pH 7.9), 10% glycerol, 0.1 mM phenylmethysufonyl fluoride] with 500 mM KC1 and centrifuged at 5000 g for 20 min. The supemant was applied onto a Ni-agarose column (Qiagene), washed with buffer B containing 500 mM KG and 10 mM imidazole, and eluted with the buffer B containing 500 mM KG and 100 mM imidazole. Eluate was dialyzed against buffer C [25 mM Hepes-KOH (pH 7.6), 40 mM To express THlh'P in Escherichia coli, an Nde\ site was introduced at the deduced initiating methionine site of TFIIFp. The resulting 0.9 kb Ndel-EcoRl fragment containing the entire open reading frame was subcloned into plasmid 6His-pET15a (18) . The histidine-tagged protein was expressed in E.coli BL21(DE3) and purified as described above.
For preparation of antibody against TFIIFp, the 0.9 kb Ndel-EcoRI cDNA fragment was subcloned into plasmid pET5a (Novagene). The expressed protein lacking the histidine-tag was purified from an SDS-polyacrylamide gel and was used to immunize New Zealand rabbits.
In vitro transcription
Antibody-conjugated beads were prepared from 1 ml of antiserum (or control serum) and 0.5 ml of Protein A-Sepharose G.4B according to the standard method (19) . To prepare TFHFdependent and control extracts, 300 uJ of nuclear extract was treated with 200 (il of antibody-immobilized Sepharose equilibrated with buffer C at 4°C for 2 h with rotation. For the in vitro transcription assay, a system was reconstituted with 5 ui of treated nuclear extract and recombinant Drosophila TFIIFa and TFIIFP, or 1 uJ of human TFTIF fraction (20) as noted in the legend to Figure 3 . Transcription activity was measured by the primer extension method as described previously (17) .
In vitro protein-protein interaction
In vitro translated 35 S-labeled Drosophila (14) and human (12) TFIIFa were prepared in a TNT coupled reticulocyte lysate system (Promega). Twenty (jJ of the translated material and 0.5 \lg of TFHFP were mixed in a final volume of 50 |xl of 0.6 x buffer B, 100 mM KG, 50 |ig/ml BSA, 0.1% NP-40. After incubating on ice for 15 min, immunoprecipitation was carried out with 10 pj of anti-Drosophila TFUFP antibody-immobilized protein A-Sepharose (Pharmacia).
RESULTS
Isolation of a cDNA encoding Drosophila TFIIFP
To isolate cDNA encoding Drosophila TFIIFp, a Drosophila cDNA library was screened with the human cDNA as a probe. Filters were hybridized in a solution containing 5 x SSPE, 0.1% A (kDa) In order to test the effect of TFUFP, the transcription system was complemented with increasing amounts of TFIIFp (lanes 3-6, 0, 10, 30 and 100 pg, respectively) in the presence of 100 pg of TFUFa. In order to test the effect of TFIIFa, the transcription system was complemented with increasing amounts of TFIIFa (lanes 7-10, 0, 10, 30 and 100 pg, respectively) in the presence of 100 pg of TFIIFp. To test the functional equivalence of the Drosophila and human IHID, the TFIlF-depleted Drosophda system was complemented with a human TFUF fraction (lane 11)
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SDS at 50°C. Reagents normally used to reduce background, including earner nucleic acids and Denhardt's solution, were omitted from the hybridized solution to facilitate detection of weakly bound probe. Under such low stringency conditions, three clones were detected which gave very weak signals but were clearly distinguishable over background. Sequence analysis showed that only one clone has a sequence similarity to human TFIIFp. The complete nucleotide and encoded amino acid sequences of the isolated cDNA are available in the GenBank (accession number U25188). The cDNA contains an openreading frame encoding a polypeptide of 277 amino acids, corresponding to a calculated molecular mass of 32 107 Da. The encoded amino acid sequence shows 51% identity with the human TFUFp sequence, with four insertion/deletion segments (Fig. 1) . The putative TFIIFP appeared to be encoded by a single gene in Drosophila. Genomic DNA blotting showed a single band when the cDNA clone isolated was used as probe (data not shown). In addition, three independent genomic clones that were isolated with the cDNA clone all share common restriction fragments (data not shown). Finally, in situs of two of the genomic clones hybridized to polytene chromosomes showed a single site of hybridization in region 86C on chromosome 3 (Fig. 2) .
Functional analysis of the encoded cDNA product
To test if the putative TFIIFp encodes functional initiation factor, the putative TFITFP and previously isolated TFIIFa (14) were expressed as fusion proteins with a histidine-tag. The recombinant proteins were purified to >95% homogeneity on a Ni-agarose 3) and human (lanes 3-6) TFUFa were incubated with (lanes 2 and 5) or without (lanes 3 and 6) Drosophila TFIIFp. Mixtures were precipitated with ann-TFITFP antibody immobilized on protein A-Sepharose Precipitated samples and 25% input amounts of the labeled proteins (lanes I and 4) were separated by SDS-PAGE and detected by autoradiography Recovery of TFIIFP by immunoprecipitation is about 30% in lanes 2 and 5 (data not shown) affinity column and migrated on an SDS-polyacrylamide gel with apparent molecular weights of 90 and 36 kDa (Fig. 3 A) . Figure 5 . Sequence similarities of TFIIFP to 0 factors (A) Scheme of structural domains of Kcoli a 7 " (B) Sequence similarities with core RNA polymerase binding domain of a factor Core RNA polymerase binding sequence of randomly selected a factors are aligned with the previously proposed segment (lower alignment) and the newly identified homology segment (upper alignment) of TFIIFp Only the residues conserved in both TFIIFP and a factors are shaded as described in Figure 1 , and marked by astensks The criteria for conservaoon in each group are >75 and >50% similarity in TFIIFp and a factors, respectively (C) Sequence similarity of TFTTFp to a subregions 4 1 and 4 2 Identical and similar ammo acids between TFIIFP and a factors are shaded as described in Figure 1 The sequences of a factors were obtained from the GenBank entries given in parentheses As a functional assay for these recombinant proteins, a ' 1 'MLF-dependent transcription system was prepared by treating Drosophila nuclear extract with antibody against the putative TFIIFp. As expected, immunoblots showed that the antibody titrated TFIIFcc, in addition to the putative THIFP, from a nuclear extract (data not shown). Consistent with these results, only a trace of transcription product was observed from the Drosophila hsp70 promoter in the depleted extract (Fig. 3B, lane 2) .
To prove that the recombinant proteins have transcription initiation activity, they were used to supplement an antibody treated nuclear extract as indicated in Figure 3B . Accurate, dose-dependent transcription was observed upon addition of both recombinant proteins, whereas neither TFIIFa nor the putative TFIIFP alone was sufficient. Moreover, transcription activity was also complemented by the addition of a HeLa fraction having TFITF activity (Fig. 3B, lane 11) . In agreement with this, the putative Drosophila TFUFp interacted with both Drosophila and human TFIIFa (Fig. 4) . From these experiments, we conclude that the isolated cDNA encodes functional Drosophila TFIIFp.
DISCUSSION
Overview of the TFHFP structure
The deduced amino acid sequence of Drosophila TFIIFP shows only -50% identity to the corresponding sequences isolated from the vertebrates, and also contains four insertion/deletion sites (Fig. 1) . Similarly, the larger TFIIF subunit, TFIIFa, also has low conservation between Drosophila and the vertebrates. In contrast to TFIIF, higher conservations (-80-90%) with almost perfect continuities have been observed in two other general transcription initiation factors, TBP and TFIIB. This observation suggests that TFIIF may contain several functional domains whose activities do not require them to be precisely positioned with respect to each other. A similar scenario has been observed in the various sequence-specific activators (for review see 22); they typically contain DNA-binding and transcription activation domains whose activities are not affected by variations in the distance separating them.
The similarity of to bacterial o factors
TFIIF interacts directly with RNA polymerase II and the complex binds to a preformed TFIIA-TFIID-TFIIB-promoter complex (23, 24) . Only TFIIFP is necessary for this recruitment of RNA polymerase II onto the promoter (23, 25) . This function of TFIIFP is analogous to that of bacterial a factors, which bind to bacterial core RNA polymerases and direct them to specific DNA binding sites. In striking support for this analogy, TFIIF forms a complex with E.coli core RNA polymerase (26) , suggesting that both TFIIFP and a factor share a common structural domain which interacts with the same core RNA polymerase site. Previously, a segment of TFTIFP (residues 111-152 in the human sequence) having homology to the core RNA polymerase binding domain of E.coli a 70 was reported (6,26) (Fig. 5B) . We note here that a better sequence similarity is present in the N-terminal region (residues 27-77 in the Drosophila sequence) (Fig. 5B) . In particular, the residues 'LRL' (384-386 in E.coli a 70 ), which are conserved in most of the a factors (reviewed in 27), are also conserved in all of the TFUFp sequences. On the other hand, McCracken and Greenblatt (26) recently showed that RNA polymerase II protected a serine residue (residue 135,136 or 142 in the human sequence) in the middle region of TFTJFp from phosphorylation in vitro. Although it indicates that the space between the middle region of TFUFP and RNA polymerase II is narrow enough to prevent access of protein kinase, it does not prove it is a direct interaction site. Thus both o homology regions are still candidates for the RNA polymerase II interaction site.
Garrett et al. (10) have reported that the carboxy region (198-251 in the rat sequence) of TFIIF P is essential for transcription activity and contains sequence similarity to the a-subregions 4.1 and 4.2. In this alignment, a gap of 16 residues was introduced between the a-subregions 4.1 and 4.2. On the other hand, we note that the same region ofTHlFjJ gives a higher homology with no gap between the two subregions to a group of a factors including a% a 28 and a 35 (reviewed in 28; Fig. 5C ). The function of a-subregion 4.1 is not clear, while region 4.2 is thought to be involved in recognition of the -35 region of bacterial promoters (27) . Since there is no evidence that TFIIF interacts with DNA, further functional analysis is required to explain these similarities.
In conclusion, we have cloned Drosophila TFUFp and reconstituted the basal transcription activity with recombinant TFTTFa and TFUFp. TFIIF is not only an essential factor for basal transcription but also a potential mediator of the signal transduction pathway from sequence-specific activators and the RNA polymerase II transcription machinery. Further study regarding functional communication between TFTIFp and TF11D will provide a new insight into transcriptional regulation.
